WHO ICTRP trial
Effects of GLP-1 Receptor Agonists on Bile Acid Metabolism and Intestinal…
KCT0004923 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0004923 |
|---|---|
| Public title | Effects of GLP-1 Receptor Agonists on Bile Acid Metabolism and Intestinal Microorganisms: Identification of Association with Nonalcoholic Fatty Liver |
| Scientific title | Effects of GLP-1 Receptor Agonists on Bile Acid Metabolism and Intestinal Microorganisms: Identification of Association with Nonalcoholic Fatty Liver |
| Primary sponsor | Kyung Hee University Hosipital at Gangdong |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Endocrine, nutritional and metabolic disease |
| Interventions | Drug : For type 2 diabetes patients with insufficient blood glucose control with metformin and sulfonlyurea 2 therapy, the drug is 1:1 randomly assigned to the group Dulaglutide (GLP-1 receptor agonist) and Empaglifluzin (SGLT2 inhibitor)… |
| Registration date | Apr 16, 2020 |
| Target size | 22 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: